Guangdong Longchuangji Pharmaceutical Co., Ltd.
Clinical trials sponsored by Guangdong Longchuangji Pharmaceutical Co., Ltd., explained in plain language.
-
Live bacteria capsule tested as new treatment for common vaginal infection
Disease control CompletedThis study tested whether a vaginal capsule containing two types of live, helpful bacteria (probiotics) could safely and effectively treat bacterial vaginosis (BV). It involved 66 women aged 18-50 with BV, who were randomly assigned to receive either the probiotic capsule or a pl…
Phase: PHASE2 • Sponsor: Guangdong Longchuangji Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Apr 02, 2026 07:11 UTC
-
Friendly bacteria challenge antibiotic for common Women's infection
Disease control CompletedThis study tested whether vaginal capsules containing live, helpful bacteria (probiotics) could safely treat bacterial vaginosis (BV), a common vaginal infection. It compared three different strengths of the probiotic capsules against the standard antibiotic treatment, metronidaz…
Phase: PHASE2 • Sponsor: Guangdong Longchuangji Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
New probiotic treatment tested for common vaginal infection
Disease control CompletedThis large, completed study tested whether vaginal capsules containing two types of helpful bacteria (probiotics) could treat bacterial vaginosis better than a placebo. It involved 402 adult women with the condition. Researchers compared how many women were cured in each group ab…
Phase: PHASE3 • Sponsor: Guangdong Longchuangji Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC